6.40% p.a. Multi Reverse Convertible
Eli Lilly, Novo Nordisk, Roche
Valor
144064081
ISIN
CH1440640816
Identifiers
144064081
CH1440640816
Yield Enhancement
Reverse Convertible
Callable Multi Reverse Convertible
1220
Parameters
Raiffeisen Switzerland B.V., Amsterdam, The Netherlands
Raiffeisen Switzerland Cooperative, St. Gallen, Switzerland
Quarterly
6.40% p.a.
Cash Settlement or Delivery of Underlying
Dirty (accrued interest included)
100%
CHF 1'000.00
CHF
Unlisted
Yes
Life Cycle
1.5 Years
02 May 2025
09 May 2025
09 May 2025
16 May 2025
16 May 2025
09 Nov 2026
16 Nov 2026
Product Specific Features
70.00%
Performance
Name Market Price
{{ underlyings['67114601'].currency }} {{ underlyings['67114601'].underlyingFeed.spot | number:2 }}
{{ underlyings['67519173'].currency }} {{ underlyings['67519173'].underlyingFeed.spot | number:2 }}
{{ underlyings['67108970'].currency }} {{ underlyings['67108970'].underlyingFeed.spot | number:2 }}
Coupons
Payment Date Amount
18 Aug 2025 1.60%
17 Nov 2025 1.60%
16 Feb 2026 1.60%
19 May 2026 1.60%
17 Aug 2026 1.60%
16 Nov 2026 1.60%
Early Redemption
Observation Date Redemption Amount
11 May 2026 100.00%
10 Aug 2026 100.00%
Eli Lilly
Eli Lilly
{{ underlyings['67114601'].currency }} {{ underlyings['67114601'].underlyingFeed.spot | number:2 }}
LLY UN
USD
NYSE
Novo Nordisk
Novo Nordisk
{{ underlyings['67519173'].currency }} {{ underlyings['67519173'].underlyingFeed.spot | number:2 }}
NOVOB DC
DKK
OMX Nordic Exchange Copenhagen
Roche
Roche
{{ underlyings['67108970'].currency }} {{ underlyings['67108970'].underlyingFeed.spot | number:2 }}
ROG SW
CHF
SIX Swiss Exchange AG